SPRY · ARS Pharmaceuticals, Inc. · Documents
$4.02
-0.01 (-0.25%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$397.79M
Shares
99.45M
Volume · Oct 26
613.93K
Avg daily vol (3M)
1.74M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-03-21 | — | |
| 8-K | — | 2024-03-07 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-11-09 | — | |
| 8-K | — | 2023-09-25 | — | |
| 8-K | — | 2023-09-20 | 2023-09-19 | |
| 8-K | — | 2023-08-10 | — | |
| 10-Q | — | 2023-08-10 | 2023-06-30 | |
| 8-K | — | 2023-06-28 | 2023-06-27 | |
| 8-K | — | 2023-05-16 | — | |
| 10-Q | — | 2023-05-15 | 2023-03-31 | |
| 8-K | — | 2023-05-15 | — | |
| 8-K | — | 2023-05-09 | — | |
| DEF 14A | — | 2023-05-01 | 2023-06-27 | |
| DEFA14A | — | 2023-05-01 | — | |
| ARS | — | 2023-05-01 | 2022-12-31 | |
| S-3 | — | 2023-04-20 | — | |
| 8-K | — | 2023-03-23 | — | |
| 10-K | — | 2023-03-23 | 2022-12-31 | |
| 8-K | — | 2023-03-13 | — | |
| 8-K | — | 2023-02-22 | — | |
| 8-K | — | 2023-02-14 | — | |
| 8-K/A | — | 2023-01-17 | 2022-11-04 | |
| 8-K | — | 2022-12-09 | 2022-12-06 | |
| 8-K | — | 2022-12-06 | — | |
| 8-K | — | 2022-11-08 | 2022-11-04 | |
| 8-K | — | 2022-11-02 | 2022-11-01 | |
| DEFA14A | — | 2022-11-02 | — | |
| 10-Q | — | 2022-11-02 | 2022-09-30 | |
| 8-K | — | 2022-10-27 | 2022-10-25 | |
| DEFA14A | — | 2022-10-27 | — | |
| DEFA14A | — | 2022-10-27 | — | |
| DEFA14A | — | 2022-10-21 | — | |
| 8-K | — | 2022-10-21 | — | |
| DEFM14A | — | 2022-10-06 | — | |
| 8-K | — | 2022-09-30 | 2022-09-27 | |
| 8-K | — | 2022-09-02 | 2022-09-01 | |
| 10-Q | — | 2022-08-11 | 2022-06-30 | |
| PREM14A | — | 2022-08-11 | — | |
| 8-K | — | 2022-07-21 | — | |
| DEFA14A | — | 2022-07-21 | — | |
| 8-K | — | 2022-06-13 | 2022-06-10 | |
| 8-K | — | 2022-05-12 | — | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| 8-K | — | 2022-05-06 | 2022-05-02 | |
| DEFA14A | — | 2022-04-28 | — | |
| DEF 14A | — | 2022-04-28 | 2022-06-10 | |
| 8-K | — | 2022-03-31 | — | |
| 10-K | — | 2022-03-31 | 2021-12-31 | |
| 8-K | — | 2022-03-17 | 2022-03-11 |
Showing 51–100 of 120 filings
Key facts
CIK
1671858
CUSIP
82835W108
13F (30d)
21 filings
21 filers
Visit website
Investor relations